全球首款心脏冷冻消融系统在沈抚示范区下线

Core Viewpoint - The world's first cardiac cryoablation system has been launched in the Shenyang-Fu Reform and Innovation Demonstration Zone, marking a significant advancement in the treatment of persistent atrial fibrillation and breaking the long-standing foreign monopoly in this field [1][3]. Group 1: Product Development - The cardiac cryoablation system features innovative technologies such as active rewarming, vacuum insulation, and backside temperature feedback, specifically designed for the surgical treatment of persistent atrial fibrillation in adult patients [1][3]. - The product was developed through a collaboration between Shenyang Pengyue Technology and the team led by Professor Wang Huishan from the Northern Theater Command General Hospital, overcoming key technical challenges over nearly five years [3][4]. - The system includes both the cryoablation device and disposable sterile cryoablation probes, which have recently received approval from the National Medical Products Administration [3]. Group 2: Industry Impact - The successful launch of this product represents a significant breakthrough in the high-end medical equipment sector in China and serves as a model for integrating medical and engineering fields, as well as for exploring new paths in industry-academia-research applications [3]. - This innovation is expected to enhance the development of the "low-temperature cryogenic medicine" industry chain and contribute to the high-end, clustered development of strategic emerging industries in Liaoning [3][4]. - The widespread adoption of this system is anticipated to optimize and upgrade maze surgical pathways, providing a safer, more efficient, and controllable treatment option for patients with persistent atrial fibrillation [4].